Palasis Maria
Insider CIK 1810701 · LYRA Principal Executive Officer, Director · BBNX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics, Inc. | A Award | 2026-05-21 | 2026-05-26 | 16,965 | — | $0 | 29,397 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | D To issuer | 2026-04-01 | 2026-04-03 | 2,000 | — | $0 | 1,094,733 | SEC↗ |
| BBNX Beta Bionics, Inc. | A Award | 2026-01-13 | 2026-01-14 | 3,997 | — | $0 | 12,432 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2026-01-06 | 2026-01-08 | 1,702 | $3.36 | $5.7K | 1,096,733 | SEC↗ |
| BBNX Beta Bionics, Inc. | S Sale | 2025-12-01 | 2025-12-02 | 500 | $29.96 | $15.0K | 8,435 | SEC↗ |
| BBNX Beta Bionics, Inc. | S Sale | 2025-12-01 | 2025-12-02 | 906 | $29.33 | $26.6K | 8,935 | SEC↗ |
| BBNX Beta Bionics, Inc. | S Sale | 2025-10-31 | 2025-11-05 | 119 | $27.45 | $3.3K | 9,841 | SEC↗ |
| BBNX Beta Bionics, Inc. | S Sale | 2025-10-31 | 2025-11-05 | 1,287 | $26.86 | $34.6K | 9,960 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2025-10-01 | 2025-10-03 | 3,667 | — | $0 | 7,333 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2025-07-10 | 2025-07-14 | 1,565 | $8.91 | $13.9K | 1,098,435 | SEC↗ |
| BBNX Beta Bionics, Inc. | A Award | 2025-03-15 | 2025-03-18 | 11,247 | — | $0 | 11,247 | SEC↗ |
| BBNX Beta Bionics, Inc. | A Award deriv | 2025-01-31 | 2025-02-03 | 9,137 | — | $0 | 9,137 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award | 2025-01-08 | 2025-01-10 | 800,000 | — | $0 | 1,100,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2024-12-09 | 2024-12-11 | 183,333 | — | $0 | 183,333 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award | 2024-10-16 | 2024-10-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2024-03-18 | 2024-03-20 | 500,000 | — | $0 | 500,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-07-12 | 150,000 | — | $0 | 150,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-26 | 150,000 | — | $0 | 150,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 250,000 | — | $0 | 250,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2022-02-16 | 2022-02-18 | 175,000 | — | $0 | 175,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2022-02-12 | 2022-02-15 | 127,400 | — | $0 | 127,400 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2021-02-08 | 2021-02-10 | 120,000 | — | $0 | 120,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2020-04-30 | 2020-05-01 | 326,303 | — | $0 | 326,303 | SEC↗ |